Terns Pharmaceuticals Inc (US: TERN) — Healthcare · Share Price, Chart & Market Data
About: Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1/2 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced metabolic stability and liver distribution that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-801 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $52.89 (+0.11%)
TERNTerns Pharmaceuticals Inc
Loading watchlist status…
Trade TERN now
Terns Pharmaceuticals Inc share price
TERN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 1:36 pm GMT+0
TERN price performance
0.057%
5D
-0.057%
1M
31.862%
YTD
1,698.98%
1Y
TERN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 1:36 pm GMT+0
TERN details
TERN Market Signals